Back to basics webinar series | Part 2
Drug testing can be complicated and requires learning the fundamentals to execute a successful, drug-free workplace program. Regardless of whether you are new to drug testing or a seasoned veteran, it is important to understand the benefits of different specimen types and which drug test best fits the unique needs of your workforce.
In the second installment of our webinar series, Back to basics, we take a closer look at oral fluid drug testing and the power of an observed collection. Join Kimberly Samano, PhD, scientific director at Quest Diagnostics, as she shares her expertise about oral fluid testing and discusses its accuracy, versatility, and effectiveness in detecting drugs.
join us on Wednesday, March 20 at 1 PM CT.
Drug and Alcohol Testing MIS Data Collection Form
Employers subject to DOT or USCG drug and alcohol testing regulations must submit their annual drug and alcohol testing data as required by their respective DOT Agency or the USCG. The annual drug and alcohol testing data being submitted for a specific calendar year is to be submitted by March 15th of the following calendar year.
Example: If you are required to submit drug and alcohol testing data for the calendar year of 2018, then you must submit your data by March 15, 2019.
When submitting their drug and alcohol testing data, employers are to use the following Drug and Alcohol Testing MIS Data Collection Form and instructions.
FMCSA Streamlines Process Allowing Individuals with Properly Managed Diabetes to Operate Commercial Motor Vehicles
FMCSA revises its regulations to permit individuals with a stable insulin regimen and properly controlled insulin-treated diabetes mellitus (ITDM) to be qualified to operate commercial motor vehicles (CMVs) in interstate commerce. Previously, ITDM individuals were prohibited from driving CMVs in interstate commerce unless they obtained an exemption from FMCSA. This rule enables a certified medical examiner (ME) to grant an ITDM individual a Medical Examiner’s Certificate (MEC), MCSA-5876, for up to a maximum of 12 months. To do so, the treating clinician (TC), the healthcare professional who manages, and prescribes insulin for, the treatment of the individual’s diabetes, provides the Insulin-Treated Diabetes Mellitus Assessment Form (ITDM Assessment Form), MCSA-5870, to the certified ME indicating that the individual maintains a stable insulin regimen and proper control of his or her diabetes. The certified ME then determines that the individual meets FMCSA’s physical qualification standards and can operate CMVs in interstate commerce.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, Federal Motor Carrier Safety Administration, 1200 New Jersey Avenue, SE., Washington, DC 20590 0001, by telephone at (202) 366-4001, or by email at email@example.com. If you have questions on viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826.
Extension of Compliance Dates for Medical Examiner's Certification Integration
FMCSA amends its regulations to delay the compliance date from June 22, 2018, to June 22, 2021, for several provisions of its April 23, 2015 Medical Examiner's Certification Integration final rule. This action is being taken to provide FMCSA additional time to complete certain information technology (IT) system development tasks for its National Registry of Certified Medical Examiners (National Registry) and provide the State Driver's Licensing Agencies (SDLAs) sufficient time to make the necessary IT programming changes after upgrades to the National Registry.
DOT is committed to ensuring that information is available in appropriate alternative formats to meet the requirements of persons who have a disability. If you require an alternative version of files provided on this page, please contact firstname.lastname@example.org.